- Title
- Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: Results from the dose-optimization stage of the REFRαME-O1 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase II/III study
- Creators
- Jung-Yun LeeAna OakninDomenica LorussoKidong KimLucy GilbertYeh Chen LeeBo GaoDavid TanAmit OzaRowan MillerDavid O'MalleyBradley MonkBhavana PothuriLin LuCraig BermanAnne BorgmanWendel Naumann
- Publication Details
- Gynecologic oncology, Vol.200, p.351
- Identifiers
- 991006226263202656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: Results from the dose-optimization stage of the REFRαME-O1 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase II/III study
Gynecologic oncology, Vol.200, p.351
09/2025
Metrics
4 Record Views